In patients with mild COVID-19, tissue-resident memory (TRM) CD8+ and CD4+ T helper-17 (Th17) cells are characterized by increasing (presumably antigen-driven) clonal expansion and strengthened effector functions, whereas their counterparts remain more naive/intermediate in critical COVID-19 [86]. This evidence concerns the gene CD8A and COVID-19.